Nutrition Timing for Sleep Disruption in ICU Patients
Trial Summary
What is the purpose of this trial?
The purpose of this study is to determine whether modifying the timing of nutrition support from overnight to daytime enhances sleep quality, preserves circadian rhythms, and improves overall inflammation and cardiometabolic profiles in postoperative patients in the cardiac surgical ICU on enteral nutrition.
Will I have to stop taking my current medications?
The trial requires that participants do not take benzodiazepines or antipsychotics. If you are on these medications, you would need to stop them to participate.
What data supports the effectiveness of the treatment for Nutrition Timing for Sleep Disruption in ICU Patients?
Is time-restricted feeding or chrononutrition generally safe for humans?
The research on time-restricted feeding and chrononutrition suggests that while there are potential benefits in aligning feeding times with natural body rhythms, there is also a risk of intestinal-related complications, especially with early enteral nutrition in critically ill patients. Overall, the safety data is inconclusive due to inconsistent study methods and definitions.12367
How does the treatment of nutrition timing for sleep disruption in ICU patients differ from other treatments?
This treatment is unique because it focuses on the timing of enteral nutrition (feeding through a tube) to align with the body's natural circadian rhythms (internal biological clock), which may help improve metabolism and recovery in ICU patients by potentially restoring disrupted sleep and biological patterns.168910
Research Team
Hassan S Dashti, Ph.D., R.D.
Principal Investigator
Massachusetts General Hospital
Eligibility Criteria
This trial is for adults over 18 who are scheduled for cardiac surgery and will stay in the ICU for more than 48 hours. They must be able to consent and follow study rules. It's not open to those with severe liver or kidney issues, dietary limits that prevent tube feeding, certain brain damage, gut absorption problems, gallbladder disease or pancreatitis, chronic use of specific sedatives or antipsychotics, sensory impairments, pregnant/nursing women, or unsafe conditions for tube feeding.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either daytime or nighttime cycled enteral feeds for 12 hours, followed by a 24-hour washout period, then switch to the opposite feeding schedule for another 12 hours.
Follow-up
Participants are monitored for changes in sleep quality, circadian rhythms, inflammation, and cardiometabolic profiles after the treatment phase.
Treatment Details
Interventions
- Time-of-day of enteral nutrition provision (daytime first)
- Time-of-day of enteral nutrition provision (nighttime first)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor